In a report released on November 15, Jason Gerberry from Bank of America Securities maintained a Buy rating on Vaxcyte (PCVX – Research ...
Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...
Shares of several vaccine makers including Pfizer and Astrazeneca were down Friday morning following the nomination of Robert ...
U.S. stocks suffered their worst loss since election day as the boost from Donald Trump's victory and a Federal Reserve ...
High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...
U.S. stocks fell to their worst loss since Election Day as the boost that Wall Street got from last week’s victory for Donald ...
Robert F. Kennedy could face some resistance as he tries to get confirmed by the Senate to be President-elect Trump's Secretary of Health and Human Services. Kennedy has said that he hopes to overhaul ...
If confirmed, Robert F. Kennedy Jr. will have broad influence over federal agencies and health care policy — a prospect that worries many in public health given his history of conspiracy theories.